NEW YORK, Nov. 9 (GenomeWeb News) - PerkinElmer disclosed the purchase price for its previously announced tender offer after markets closed yesterday.
Â
As GenomeWeb News reported yesterday afternoon, PerkinElmer received consents from its noteholders approving its cash tender offer for outstanding notes.
Â
PerkinElmer anticipates Nov. 14 as the initial settlement date.
Â
Holders who tender notes prior to the settlement date will receive total consideration per $1,000 principal amount of notes tendered of $1,119.64. This includes the consent payment of $20 and accrued and unpaid interest up to the payment date.
Â
Holders who tender notes between the settlement date and expiration date of Nov.23, 9:00am, will receive total consideration per $1,000 principal amount of notes tendered of $1,118.65. This also includes the consent payment and accrued and unpaid interest.
Â
The purchase price was calculated with the bid-side price of the US Treasury Note as indicated on Bloomberg screen PX5 at 2:00pm New York City time yesterday, the company said.
Â
The company also said today that $269.9 million, or 99.6% of the aggregate outstanding principal amount of notes was validly tendered. The company had said 96% yesterday.